Overview
Once-weekly semaglutide (2.4 mg) in adjunct with diet and exercise, is effective for weight loss in non-diabetic obese or overweight adults, finds a recent study in the New England Journal of Medicine.
According to WHO, obesity is a global health challenge whose prevalence has nearly tripled worldwide since 1975. Few pharmacologic options further makes the situation even more worse. Semaglutide is an anti-diabetic medicine approved for the treatment of type 2 diabetes.
For more details, check out the full story on the link below:
Speakers
Dr. Nandita Mohan is a practicing pediatric dentist with more than 3 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped.